TL;DR: Talus Bio is a Y Combinator Summer 2021 startup Discovering drugs that target the DNA regulome, currently active with a team of 16.
Discovering drugs that target the DNA regulome
Last verified:
We have built a platform that enables drug discovery and development for previously undruggable genome regulators ("the regulome"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment.
Built by LemStudio
Yes. Talus Bio was funded by Y Combinator in the Summer 2021 batch. Discovering drugs that target the DNA regulome
We have built a platform that enables drug discovery and development for previously undruggable genome regulators ("the regulome"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovation…
Talus Bio was part of Y Combinator's Summer 2021 batch.
Talus Bio has a team of 16 people according to Y Combinator's directory.
Talus Bio is currently listed as Active with a team of 16 in Y Combinator's directory.
Loading interactive view…